Dextromethorphan Hydrobromide And Quinidine Sulfate Capsule
Product Images NDC 31722-693

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Dextromethorphan Hydrobromide And Quinidine Sulfate (NDC 31722-693). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image
FDA Label Image

Dextroandquinicontainerlabel (Dextroandquinicontainerlabel)

Dextroandquinicontainerlabel (Dextroandquinicontainerlabel)
This is a drug label for Dextromethorphan Hydrobromide and Quinidine Sulfate Capsules. Each capsule contains 20 mg of dextromethorphan hydrobromide, USP and 10 mg of quinidine sulfate, USP. The usual dosage information is provided in the package insert. It is important to keep this medication out of reach of children and store it at 20° to 25°C (68° to 77°F). Light and moisture should be avoided to maintain the integrity of the medication. The manufacturer is Camber Pharmaceuticals, Inc., and the product is distributed by HETERO™, Hetero Labs Limited in Hyderabad, India.*
FDA Label Image

Dextromethorphan-hydrobromide-structure (Dextromethorphan Hydrobromide Structure)

FDA Label Image

Quinidine-sulfate-structure (Quinidine Sulfate Structure)

Quinidine-sulfate-structure (Quinidine Sulfate Structure)
Not available.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.